Business
NEXT SUPER STOCKS On The Move: Skylight Health, Reliq Health Tech, Delic Holdings, and Relay Medical
NEXT SUPER STOCKS On The Move: Skylight Health, Reliq Health Tech, Delic Holdings, and Relay Medical.
About this update from Skylight Health Group Inc.
[{"type":"text","content":"\n NEW YORK, March 11, 2021 (GLOBE NEWSWIRE) -- Wall Street Reporter, the trusted name in financial news since 1843, is highlighting the latest CEO comments and news from companies recently presenting at its highly acclaimed NEXT SUPER STOCK livestream investor conferences, and investor “LiveChats” on social media streams. Over 100,000 investors have participated in Wall Street Reporter’s livestream events in the past 30 days. Skylight Health Group (TSX.V: SHG) (OTC: SHGFF) CEO, Prad Sekar: “Now At Inflection Point - Positioned for 10X Upside Revenue Growth Potential” Skylight Health Group (TSX.V: SHG) (OTC: SHGFF) was recently a featured presenter at Wall Street Reporter’s NEXT SUPER STOCK livestream investor conference. CEO Prad Sekar, outlined his vision for building Skylight into a multi-billion dollar business focused on the highly fragmented US healthcare market. Skylight already operates 30 clinics, in 14 states, with virtual telehealth overlay, serving over 120,000 patients - and is one of the fastest growing multi-disciplinary health systems in the United States. Watch Skylight (OTC: SHGFF) Next Super Stock 3/4/21 video: http://bit.ly/3qAZAAr Skylight is now at an inflection point. SHGFF revenues are expected to be $56 million and $5.5 million EBITDA run rates, with a recently announced acquisition. SHGFF boasts a profitable base of operations, no long-term debt and cash balance of $10 million. In his presentation, Skylight CEO Prad Sekar, explains how the company can increase revenues organically by about 10X, as it optimizes clinics for profitability by expansion of services to the existing patient base, with its proven business model, stating: \"$200 Million Revenues Run Rate in 2021 Is Goal.\" March 4 - SHGFF has entered into Letters of Intent (LOIs) to acquire 3 independent Primary Care practices in the United States, immediately adding over $10 million in revenue and positive EBITDA when closed. The transactions have a target closing price of between 4 – 5 x EBITDA which is consistent with the Company’s 5 recent transactions. The average purchase price for the combined assets averages below 1 x revenue. Watch Skylight (OTC: SHGFF) Next Super Stock 3/4/21 video: http://bit.ly/3qAZAAr Reliq Health Technologies (OTC:RQHTF) (TSX.V:RHT) CEO Lisa Crossley: “2021 is B...